- Reaction score
- 292
But what business model have they presented after performing clinical trials? Stemson has a clear one where tsuji just appears to be focused on researchInto "clinics" does not mean actually into doctors offices, it means human trials in general. Small scale testing on humans would be phase 1 trails, the same process Stemson will go through.
what exactly will they do if they prove successful HM in humans? They have mentioned human application, but that’s about it whereas Stemson has mentioned in their presentations their goal to work with current transplant clinics to deliver this sort of tech
Last edited: